79 FR 8 pg. 2156 - Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning Anti-Filovirus Therapeutics
Type: NOTICEVolume: 79Number: 8Page: 2156
Page: 2156FR document: [FR Doc. 2014-00290 Filed 1-10-14; 8:45 am]
Agency: Defense Department
Sub Agency: Army Department
Official PDF Version: PDF Version
[top]
DEPARTMENT OF DEFENSE
Department of the Army
Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning Anti-Filovirus Therapeutics
AGENCY:
Department of the Army, DoD.
ACTION:
Notice.
SUMMARY:
Announcement is made of the availability for licensing of the invention set forth in U.S. Provisional Patent Application Serial No. 61/761,942, entitled "Anti-Filovirus Therapeutics," filed on February 7, 2013. The United States Government, as represented by the Secretary of the Army, has rights to this invention.
ADDRESSES:
Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702-5012.
FOR FURTHER INFORMATION CONTACT:
For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul Mele, Office of Research and Technology Applications (ORTA), (301) 619-6664, both at telefax (301) 619-5034.
SUPPLEMENTARY INFORMATION:
The invention relates to an antisense oligonucleotide directed to a mRNA encoding a mammalian Niemann-Pick C1 (NPC1) receptor, and combinations thereof and compositions comprising such are provided. Also provided are methods of treating or reducing filovirus infection of a subject.
Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2014-00290 Filed 1-10-14; 8:45 am]
BILLING CODE 3710-08-P